Skip to main content
Premium Trial:

Request an Annual Quote

Neuropsychiatric Consortium Uses Ingenuity Software for Mental Disorder Pathway Analysis

NEW YORK (GenomeWeb News) - Ingenuity Systems said today that a group of researchers studying neuropsychiatric disorders will use its pathway analysis software to track genetic links to certain diseases.
 
The Pritzker Neuropsychiatric Disorders Research Consortium will use the Ingenuity Pathway Analysis software in research aimed at understanding the genetic and biological causes of disorders such as depression, manic depression, bipolar disorder, and schizophrenia in order to identify targets for treatments.
 
The PNDRC includes researchers and groups at the University of Michigan, Weill Medical College of Cornell University, Stanford University, the University of California at Irvine, and the University of California at Davis.
 
The consortium will use the software to study customized pathways that can link gene expression profiles to functions, diseases, pathways and molecular mechanisms, the company said.
 
Financial terms of the agreement were not released.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.